Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Untreated B-CLL”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02100423
What this trial is testing

Curcumin and Cholecalciferol in Treating Patients With Previously Untreated Stage 0-II Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Contiguous Stage II Small Lymphocytic LymphomaNoncontiguous Stage II Small Lymphocytic LymphomaStage 0 Chronic Lymphocytic Leukemia+3 more
Paolo Caimi, MD 35
Not applicableStudy completedNCT02037256
What this trial is testing

Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisB-cell Chronic Lymphocytic LeukemiaContiguous Stage II Adult Burkitt Lymphoma+86 more
Barbara Ann Karmanos Cancer Institute 23
Testing effectiveness (Phase 2)Study completedNCT00602459
What this trial is testing

Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia

Who this might be right for
Stage I Chronic Lymphocytic LeukemiaStage II Chronic Lymphocytic LeukemiaStage III Chronic Lymphocytic Leukemia+1 more
National Cancer Institute (NCI) 418
Early research (Phase 1)Study completedNCT00024180
What this trial is testing

FR901228 in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphoma
Ohio State University Comprehensive Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06333262
What this trial is testing

Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Inhye Ahn 60
Early research (Phase 1)UnknownNCT01976520
What this trial is testing

Vaccine Therapy for Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
XEME Biopharma Inc. 30
Testing effectiveness (Phase 2)Study completedNCT01496976
What this trial is testing

Ofatumumab, High Dose Methylprednisolone, Ofatumumab and Lenalidomide Consolidative Therapy for Untreated CLL/SLL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
H. Lee Moffitt Cancer Center and Research Institute 45
Testing effectiveness (Phase 2)Ended earlyNCT02557516
What this trial is testing

Combination Study of IPH2201 (Monalizumab) With Ibrutinib in Relapsed, Refractory or Previously Untreated CLL

Who this might be right for
Chronic Lymphocytic Leukemia
Innate Pharma 22
Large-scale testing (Phase 3)Study completedNCT01905943
What this trial is testing

A Safety and Efficacy Study of Obinutuzumab Alone or in Combination With Chemotherapy in Participants With Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Hoffmann-La Roche 979
Testing effectiveness (Phase 2)Study completedNCT00003425
What this trial is testing

Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect

Who this might be right for
Breast CancerLeukemiaLymphoma+4 more
University of Kentucky 25
Early research (Phase 1)Study completedNCT00062140
What this trial is testing

Total-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+1 more
Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT01300247
What this trial is testing

Obinutuzumab (GA101; RO5072759) in Combination With Chemotherapy in Participants With Previously Untreated Chronic Lymphocytic Leukemia (CLL) (GALTON)

Who this might be right for
Lymphocytic Leukemia, Chronic
Genentech, Inc. 41
Testing effectiveness (Phase 2)Study completedNCT00004132
What this trial is testing

Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLeukemiaLymphoma+3 more
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT00004258
What this trial is testing

EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Indiana University 40
Testing effectiveness (Phase 2)UnknownNCT00008307
What this trial is testing

Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Herbert Irving Comprehensive Cancer Center 52
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07582159
What this trial is testing

Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaChronic Lymphocytic Leukemia/Small Lymphocytic LymphomaSmall Lymphocytic Lymphoma
City of Hope Medical Center 35
Early research (Phase 1)Study completedNCT01292603
What this trial is testing

Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Lymphocytic Leukemia, Chronic
Hoffmann-La Roche 240
Testing effectiveness (Phase 2)Study completedNCT00525603
What this trial is testing

CFAR Study in Patients With Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaChronic Lymphocytic Leukemia
M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)Study completedNCT00536341
What this trial is testing

Fludarabine, Rituximab, and Lenalidomide in Minimally Treated/Untreated Patients With Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia
SCRI Development Innovations, LLC 64
Next Page